- Report
- June 2025
- 268 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 279 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 282 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 470 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 171 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 490 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 377 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 371 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 279 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 468 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 467 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 282 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 288 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 278 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 220 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 474 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 285 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 481 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- March 2025
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- March 2025
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more